Zynerba initiates phase II trial of Zygel to treat behavioral symptoms in 22q11.2 deletion syndrome May 29, 2019
FDA approves Revlimid with rituximab for previously treated FL and marginal zone lymphoma May 29, 2019
Researchers develop new murine model of dystrophic epidermolysis bullosa-squamous cell carcinoma May 29, 2019
ProMIS identifies antibody candidates that selectively bind toxic oligomers of tau for Alzheimer's May 29, 2019
RSS